COMPARISON OF THE CHROMOGENIC AND ONE-STAGE ASSAYS FOR FACTOR IX
COMPARISON OF THE CHROMOGENIC AND ONE-STAGE ASSAYS FOR FACTOR IX
批准号:
3804918
负责人:
W FRICKE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
一阶段凝血试验是最广泛使用的
测定因子IX活性的方法。 它是基于
通过添加以下物质校正fIX缺乏血浆的凝血时间
的fix。 最近,已经开发了一种新的fIX测定法,
涉及将fIX加入到fXIa和fX的制剂中。 的
添加的fIX的量可以由酶的裂解速率来确定。
通过Xa因子显色底物。 我们已经进行了正式的
用于确定的凝血和显色测定的比较
因子IX浓缩物的效力。 测定的多重比较
使用CBER当前的fIX标准,FN2与当前的WHO标准,
84/618,证明了两种方法的等效性。 FN2的价值
凝集试验为9.3,显色试验为9.1。
提交给CBER的多批因子IX浓缩物的比较
测试表明,方法之间存在显著差异,
一些浓缩物。 如果能在某种程度上减少这种分歧,
显色试验是动态读取的,而不是使用终点
法 进一步的比较研究正在进行中。
英文摘要
The one-stage clotting assay is the basis for the most widely used
method for determining factor IX activity. It is based on the
correction of the clotting time of fIX deficient plasma by the addition
of fIX. Recently, a new assay for fIX has been developed that assay
involves the addition of fIX to a preparation of fXIa and fX. The
amount of fIX added can be determined from the rate of cleavage of a
chromogenic substrate by factor Xa. We have undertaken a formal
comparison of the clotting and chromogenic assays for determining
potency of factor IX concentrates. Multiple comparisons of the assays
using CBER's current fIX standard, FN2 versus the current WHO standard,
84/618, demonstrated equivalence of the two methods. The value of FN2
by clotting assay was 9.3 and 9.1 for the chromogenic assay.
Comparisons of multiple lots of factor IX concentrates submitted to CBER
for testing indicated significant disagreement between the methods for
some concentrates. This disagreement could be somewhat reduced when the
chromogenic assay was read kinetically rather than using the endpoint
method. Further comparative studies are in progress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EPITOPE MAPPING OF ANTIBODIES TO VON WILLEBRAND FACTOR
-
批准号:3792657
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W FRICKE
-
依托单位:
ACTIVATION OF FVIII BY FXA AND INHIBITION BY TISSUE FACTOR PATHWAY INHIBITOR
-
批准号:3804919
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W FRICKE
-
依托单位:
EPITOPE MAPPING OF ANTIBODIES TO FACTOR VIII
-
批准号:3792656
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W FRICKE
-
依托单位:
EPITOPE MAPPING OF FACTOR VIII AND VON WILLEBRAND FACTOR
-
批准号:3770445
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W FRICKE
-
依托单位:--
EFFECT OF FACTOR XIA ON FACTOR VIII
-
批准号:3770444
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W FRICKE
-
依托单位:--
CHARACTERIZATION OF THE FACTOR VIII IN FACTOR VIII CONCENTRATES
-
批准号:3792653
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W FRICKE
-
依托单位:
HIV INFECTION DUE TO CLOTTING FACTOR CONCENTRATES--RESULTS OF THE SSP
-
批准号:3792655
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W FRICKE
-
依托单位:
SEROCONVERSION SURVEILLANCE PROJECT
-
批准号:3804917
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W FRICKE
-
依托单位:
海外基金